NO_LONGER_AVAILABLENCT00862758

Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oklahoma
Principal Investigator
Kathleen O'Neil, M.D.
University of Oklahoma
Intervention
Tocilizumab(drug)
Eligibility
11-12 years · MALE
Timeline
2009 – 2010

Study locations (1)

Collaborators

Hoffmann-La Roche

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00862758 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis →

← Back to all trials